Cell Therapy Manufacturing Market 2018 - Increasing Number Of Surgical Procedures Performed Across The World Coupled With Increasing Number Of Trauma And Accidents Is Propelling Demand For New Medical Therapy

Cell therapy is one of the most promising healthcare procedure for restoration of damaged tissue. Cell therapies have huge potential for the wide range of disease treatment including tissue degradation, immune deficiency, metabolic disorders, and cancer. Cell therapy are categorized into two type’s allogeneic (cells from third party donor) and autologous (cells from one’s own body). Cell therapy has gained significant traction in recent past and currently it under commercial development. Main objective of cell therapy is to re-establish the lost function of tissues and cells rather than to produce a new organ. Some cell therapies have been established and permitted for clinical trial. For instance, in 2013 a stage 2 clinical trial was completed for transplantation of bone marrow derived stem cells in affected knee by rheumatoid arthritis. The growth of this technique is also increased due to involvement of the government agencies. For instance, innovate U.K. 2014 report showed that government agreed to fund US$15.3 million in cell therapy manufacturing market.

Get FREE In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/1728

Cell Therapy Manufacturing Market Dynamics

Increasing number of surgical procedures performed across the world coupled with increasing number of trauma and accidents is propelling demand for new medical therapy. For instance, according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell transplants are carried out annually worldwide for various surgeries. Stem cells transplantation is promising medical therapy for patients with advance stage diseases like Alzheimer’s, arthritis, autism, blindness, cancer, cerebral palsy, diabetes etc. Key biopharmaceutical companies are majorly investing in research for cell therapy. For instance, Longeveron LL, a biopharmaceutical company received a US$ 750,000 grant from the Maryland Technology Development Corporation (TEDCO) in 2018 for stem cell therapy research. These collaborations and government funding are boosting growth of the cell therapy manufacturing market. However, the strict regulations, guidelines, and various health safety concerns over cell therapy treatment are restraining growth of the cell therapy market.

Cell Therapy Manufacturing Market - Regional Insights

On the basis of the region, the global cell therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global cell therapy manufacturing market, owing to large number of surgeries performed in the region as well as development of technologically advanced products for therapy. According to the National Health Statistics Report by the Centers for Disease Control & Prevention (CDC), around 201,748.3 million surgical and non-surgical procedures were performed in the U.S. in 2011.

Cell Therapy Manufacturing Market - Competitive Insights

The key player operating in the global cell therapy manufacturing market include,

1. Pharmicell
2. Merck Group
3. Dickinson and Company
4. Thermo Fisher
5. Lonza Group
6. Miltenyi Biotec GmBH
7. Takara Bio Group
8. STEMCELL Technologies
9. Cellular Dynamics International
10. Becton
11. Osiris Therapeutics
12. Bio-Rad Laboratories, Inc.
13. Anterogen
14. MEDIPOST
15. Holostem Terapie Avanazate
16. Pluristem Therapeutics
17. Brammer Bio
18. CELLforCURE
19. Gene Therapy Catapult EUFETS
20. MaSTherCell
21. PharmaCell
22. Cognate BioServices
23. WuXi AppTec

Key players are adoption growth strategies such as collaborations, introduction of new technologies and devices to maintain dominant position in the market. For instance, in 2014, ViaCyte, Inc. successfully implanted VC-01 an embryonic stem cell derived islet for the treatment of type 1 diabetes.

Cell Therapy Manufacturing Market Taxonomy:

On the basis of therapy type, the global cell therapy manufacturing market is segmented into:

Allogeneic Cell Therapy
Autologous Cell Therapy

On the basis of Technology:

Somatic Cell Technology
Cell Immortalization Technology
Viral Vector Technology
Genome Editing Technology
Cell Plasticity Technology
3D Technology

On the basis of Source:

IPSC’s (Induced pluripotent stem cell)
Bone marrow
Umbilical cord
Adipose tissue
Neural stem

On the basis of Application:

Musculoskeletal
Cardiovascular
Gastrointestinal
Neurological
Oncology
Dermatology
Others

On the basis of Region:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

For More Details About This Exclusive Research, Talk to Our Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1728

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.